0001794644-19-000002.txt : 20191121 0001794644-19-000002.hdr.sgml : 20191121 20191121151007 ACCESSION NUMBER: 0001794644-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191121 DATE AS OF CHANGE: 20191121 EFFECTIVENESS DATE: 20191121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lipidio Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001794644 IRS NUMBER: 825402487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-353962 FILM NUMBER: 191237298 BUSINESS ADDRESS: STREET 1: 3570 CARMEL MOUNTAIN RD STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8584368000 MAIL ADDRESS: STREET 1: 3570 CARMEL MOUNTAIN RD STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Lipidio Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20191120 D 1 primary_doc.xml X0708 D LIVE 0001794644 Lipidio Pharmaceuticals Inc. 3570 CARMEL MOUNTAIN RD STE 200 SAN DIEGO CA CALIFORNIA 92130 8584368000 DELAWARE GDD Therapeutics, Inc. Lipidio Pharmaceuticals, Inc. Corporation true 2019 David Bullough 3570 Carmel Mountain Rd., Suite 200 San Diego CA CALIFORNIA 92130 Director J. Gordon Foulkes 3570 Carmel Mountain Rd.,Suite 200 San Diego CA CALIFORNIA 92130 Executive Officer Director Daniel Petree 3570 Carmel Mountain Rd., Suite 200 San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06b false 2019-11-08 false true true false 0 Maxim Group LLC 120708 None None 405 Lexington Ave, 2nd FL New York NY NEW YORK 10174 All States false 12000000 4622530 7377470 false 58 462253 true 0 In addition to the Sale Commissions, a warrant to purchase 358,338 shares of the Issuer's common stock was issued. 0 false Lipidio Pharmaceuticals Inc. /s/ J. Gordon Foulkes J. Gordon Foulkes CEO 2019-11-21